These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 28445956)
21. An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway. Leng C; Zhang ZG; Chen WX; Luo HP; Song J; Dong W; Zhu XR; Chen XP; Liang HF; Zhang BX Cancer Lett; 2016 Jun; 376(1):188-96. PubMed ID: 26996299 [TBL] [Abstract][Full Text] [Related]
22. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression. Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398 [TBL] [Abstract][Full Text] [Related]
23. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA. Li J; Ma C; Huang Y; Luo J; Huang C Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890 [TBL] [Abstract][Full Text] [Related]
24. [Expression of RHBDD1 gene in patients with chronic myeloid leukemia and its clinical significance]. Lin YN; Gui FM; Shen H; Wang F; Cao Z; Li QH; Wang JX; Pang TX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):12-5. PubMed ID: 23484682 [TBL] [Abstract][Full Text] [Related]
25. Cdk3-promoted epithelial-mesenchymal transition through activating AP-1 is involved in colorectal cancer metastasis. Lu J; Zhang ZL; Huang D; Tang N; Li Y; Peng Z; Lu C; Dong Z; Tang F Oncotarget; 2016 Feb; 7(6):7012-28. PubMed ID: 26755651 [TBL] [Abstract][Full Text] [Related]
26. Dominant-negative mutant of c-Jun gene transfer: a novel therapeutic strategy for colorectal cancer. Suto R; Tominaga K; Mizuguchi H; Sasaki E; Higuchi K; Kim S; Iwao H; Arakawa T Gene Ther; 2004 Jan; 11(2):187-93. PubMed ID: 14712303 [TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer. Zhang Z; Zhou C; Chang Y; Zhang Z; Hu Y; Zhang F; Lu Y; Zheng L; Zhang W; Li X; Li X Cancer Lett; 2016 Jun; 376(1):62-73. PubMed ID: 27012187 [TBL] [Abstract][Full Text] [Related]
28. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling. Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576 [TBL] [Abstract][Full Text] [Related]
29. Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation. Zhang Y; Xue C; Zhu X; Zhu X; Xian H; Huang Z Cell Signal; 2016 Aug; 28(8):850-60. PubMed ID: 27094723 [TBL] [Abstract][Full Text] [Related]
30. CREB1 directly activates the transcription of ribonucleotide reductase small subunit M2 and promotes the aggressiveness of human colorectal cancer. Fang Z; Lin A; Chen J; Zhang X; Liu H; Li H; Hu Y; Zhang X; Zhang J; Qiu L; Mei L; Shao J; Chen X Oncotarget; 2016 Nov; 7(47):78055-78068. PubMed ID: 27801665 [TBL] [Abstract][Full Text] [Related]
31. Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib ("Iressa") and the DNA topoisomerase I inhibitor CPT-11 (irinotecan) in human colorectal cancer cells. Koizumi F; Kanzawa F; Ueda Y; Koh Y; Tsukiyama S; Taguchi F; Tamura T; Saijo N; Nishio K Int J Cancer; 2004 Jan; 108(3):464-72. PubMed ID: 14648715 [TBL] [Abstract][Full Text] [Related]
32. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway. Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069 [TBL] [Abstract][Full Text] [Related]
33. CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5-AP-1 axis. Zhuang K; Zhang J; Xiong M; Wang X; Luo X; Han L; Meng Y; Zhang Y; Liao W; Liu S Cell Death Dis; 2016 Oct; 7(10):e2415. PubMed ID: 27735944 [TBL] [Abstract][Full Text] [Related]
34. Lentiviral vector mediated delivery of RHBDD1 shRNA down regulated the proliferation of human glioblastoma cells. Wei X; Lv T; Chen D; Guan J Technol Cancer Res Treat; 2014 Feb; 13(1):87-93. PubMed ID: 23883433 [TBL] [Abstract][Full Text] [Related]
35. High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin. Wang ZN; Liu D; Yin B; Ju WY; Qiu HZ; Xiao Y; Chen YJ; Peng XZ; Lu CM Oncotarget; 2017 May; 8(22):36185-36202. PubMed ID: 28404950 [TBL] [Abstract][Full Text] [Related]
36. Gas1 Inhibits Metastatic and Metabolic Phenotypes in Colorectal Carcinoma. Li Q; Qin Y; Wei P; Lian P; Li Y; Xu Y; Li X; Li D; Cai S Mol Cancer Res; 2016 Sep; 14(9):830-40. PubMed ID: 27401611 [TBL] [Abstract][Full Text] [Related]
37. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963 [TBL] [Abstract][Full Text] [Related]
38. Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial-mesenchymal transition. Nam EH; Lee Y; Moon B; Lee JW; Kim S Carcinogenesis; 2015 Mar; 36(3):327-37. PubMed ID: 25600770 [TBL] [Abstract][Full Text] [Related]
39. Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression. Mann JR; Backlund MG; Buchanan FG; Daikoku T; Holla VR; Rosenberg DW; Dey SK; DuBois RN Cancer Res; 2006 Jul; 66(13):6649-56. PubMed ID: 16818638 [TBL] [Abstract][Full Text] [Related]
40. Pinin facilitated proliferation and metastasis of colorectal cancer through activating EGFR/ERK signaling pathway. Wei Z; Ma W; Qi X; Zhu X; Wang Y; Xu Z; Luo J; Wang D; Guo W; Li X; Xin S; Yu J; Li G Oncotarget; 2016 May; 7(20):29429-39. PubMed ID: 27107420 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]